Joubert syndrome with ocular defect

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:220493OMIM:608629H35.5Q04.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Joubert syndrome with ocular defect (also known as Joubert syndrome type 2 or JS-related disorders with retinal involvement) is a rare genetic neurodevelopmental disorder characterized by the hallmark 'molar tooth sign' on brain MRI — a distinctive malformation of the cerebellar vermis and brainstem — combined with significant ocular abnormalities. This condition belongs to the broader group of Joubert syndrome and related disorders (JSRD), a family of ciliopathies caused by dysfunction of primary cilia, which are critical cellular structures involved in signaling during embryonic development. The neurological features include hypotonia (low muscle tone) in infancy, developmental delay, intellectual disability of variable severity, abnormal breathing patterns (episodic hyperpnea/apnea) in the neonatal period, and ataxia (impaired coordination). The defining ocular features in this subtype include retinal dystrophy, such as Leber congenital amaurosis or retinitis pigmentosa-like changes, as well as colobomas (gaps in eye structures), nystagmus, and oculomotor apraxia (difficulty with voluntary eye movements). These eye findings can lead to significant visual impairment or blindness. The retinal involvement distinguishes this subtype from other forms of Joubert syndrome. There is currently no cure for Joubert syndrome with ocular defect. Management is supportive and multidisciplinary, involving neurologists, ophthalmologists, developmental specialists, and physical/occupational therapists. Early intervention programs for developmental delays, management of breathing abnormalities, and regular ophthalmologic monitoring are essential components of care. Surveillance for potential kidney and liver involvement is also recommended, as some genetic subtypes may develop renal or hepatic complications over time. Genetic counseling is important for affected families. Multiple genes have been implicated, including CEP290, AHI1, CC2D2A, and others, all encoding proteins involved in ciliary function.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormality of the hypothalamus-pituitary axisHP:0000864DextrocardiaHP:0001651Foot polydactylyHP:0001829
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Joubert syndrome with ocular defect.

View clinical trials →

No actively recruiting trials found for Joubert syndrome with ocular defect at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Joubert syndrome with ocular defect community →

No specialists are currently listed for Joubert syndrome with ocular defect.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Joubert syndrome with ocular defect.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Joubert syndrome with ocular defectForum →

No community posts yet. Be the first to share your experience with Joubert syndrome with ocular defect.

Start the conversation →

Latest news about Joubert syndrome with ocular defect

No recent news articles for Joubert syndrome with ocular defect.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Joubert syndrome with ocular defect

What is Joubert syndrome with ocular defect?

Joubert syndrome with ocular defect (also known as Joubert syndrome type 2 or JS-related disorders with retinal involvement) is a rare genetic neurodevelopmental disorder characterized by the hallmark 'molar tooth sign' on brain MRI — a distinctive malformation of the cerebellar vermis and brainstem — combined with significant ocular abnormalities. This condition belongs to the broader group of Joubert syndrome and related disorders (JSRD), a family of ciliopathies caused by dysfunction of primary cilia, which are critical cellular structures involved in signaling during embryonic development.

How is Joubert syndrome with ocular defect inherited?

Joubert syndrome with ocular defect follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Joubert syndrome with ocular defect typically begin?

Typical onset of Joubert syndrome with ocular defect is neonatal. Age of onset can vary across affected individuals.